EFFECTS OF ELECTROCHEMOTHERAPY ON MURINE LEWIS LUNG CARCINOMA CELL LINE

Eivina Radzevičiūtė1, Veronika Malyško-Ptašinskė2, Irutė Girkontaitė1, Vitalij Novickij2

1 State Research Institute Centre for Innovative Medicine, Department of Immunology, Vilnius, Lithuania

2 Faculty of Electronics, Vilnius Gediminas Technical University, Vilnius, Lithuania

Chemotherapy is the most often used way to treat cancer patients worldwide despite drug resistance, low efficiency, and many adverse side effects on patients [1]. Therefore, this encourages to search for novel cancer treatment methods. Electrochemotherapy (ECT) is the application of pulsed electric fields (PEF) to introduce chemotherapeutic drugs through membrane pores into target cells for cancer treatment. For decades used standard microsecond ECT procedure (µsECT) induces side effects while nanosecond electrochemotherapy (nsECT) causes lower tumor cell viability, better drug delivery, and less tumor-surrounding tissue necrosis [2].

In this work, we analyzed the effects of different conditions of nsECT with bleomycin (BLEO) and doxorubicin (DOX) on murine Lewis lung carcinoma (LLC1) cell line. nsECT conditions differ from each other by pulse duration (100–500 ns), electric field strength (5–10 kV/cm), and frequency (10 kHz, 100 kHz, 1 MHz). Electric pulses were applied using 0–3 kV, 100 ns–1 ms square wave high voltage and high up to 1 MHz frequency pulse generator [3]. Cell permeabilization was evaluated by using Yo-Pro1. The cells were mixed with a stain for the final concentration of 1 μM and treated with different nsECT protocols. Afterwards, the samples were analyzed by flow cytometry. Moreover, we evaluated optimal chemotherapeutics concentration (BLEO 0,8 – 100 μg/ml; DOX 0,2 – 5,8 μg/ml) using standard microsecond electroporation. Using determined drugs concentrations, different conditions of nsECT effect on carcinoma cells viability were assessed. The LLC1 cells (25 μl) were mixed with drugs (25 μl) where 50 μl samples were placed between the electrodes and treated by PEF, transferred to 96-well plate followed by 20 min incubation on ice. Afterward, 150 μ of growth media was added to the well and the sample left for incubation period. Subsequently, cells viability was evaluated after 24, 48, and 72 hours using Alamar blue reagent.

This study showed that the permeabilization rate of LLC1 cells was increasing, while increasing pulse duration and electric field from 5 up to 10 kV/cm. However, it was observed that 5 kV/cm electric field strength was less effective in comparison with the results obtained with different electric pulse strength, frequency and duration. Consequently, was no longer used in nsECT viability experiments. For further viability experiments, bleomycin and doxorubicin concentrations were selected depending on the largest viability difference between LLC1 + drug and LLC1 + nsECT groups to ensure low drug toxicity itself. The most significant difference in cell viability was observed following 72 h incubation after µsECT with bleomycin and 48 h with doxorubicin. Results after 24 hours showed high cell viability and, therefore, weak treatment outcome. For nsECT it was noticed that while increasing pulse duration cells viability declines gradually. It was observed, that the best cells response was reached applying pulses from 300 to 500 ns duration, while 100 and 200 ns pulses had little to no effect on cell viability. Moreover, as it was expected, higher electric field strength initiated lower cell viability, though, the notable treatment outcome is detected with 8 – 10 kV/cm, when viability goes under 50 %. Nevertheless, the most significant results were obtained with 1 MHz frequency protocols, where even 6 kV/cm triggered cell response to electrochemotherapy (below 30 % viability after 48 h) with both drugs.

Our study shows that high frequency nsECT with bleomycin and doxorubicin could be as effective as standard microsecond treatment procedures. Collected nsECT results confirmed cell permeabilization results – nanosecond electroporation permeabilized cells create pores that ensure better antineoplastic drugs delivery to the cancer cells. Although, further in vivo studies need to be performed.

Acknowledgments: The research was funded by Research Council of Lithuania within the DAINA framework, Grant Nr. S-LL-21-4


[1] Bukowski K, Kciuk M, Kontek R. Mechanisms of Multidrug Resistance in Cancer Chemotherapy. Int J Mol Sci. 2020;21(9):3233.

[2] Novickij et al. Electrochemotherapy using doxorubicin and nanosecond electric field pulses: A pilot in vivo study. Molecules, 25(20), 2020.

[3] V. Novickij et al., High-frequency submicrosecond electroporator. Biotechnol. Biotechnol. Equip., vol. 30, no. 3, pp. 607-613, May 2016.